MedTrace Logo

Antibacterial Treatment Against Diarrhea in Oral Rehydration Solution

NCT00937274 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-11-13

No results posted yet for this study

Summary

This study hopes to demonstrate the potentials of a new form of therapy for childhood diarrhea, a major cause of morbidity and deaths in Bangladesh and other developing countries, and thus a priority for improving child health.

Conditions

Interventions

OTHER

T4 phage cocktail test

T4 phages 106 PFU/ ml up to 5 days

OTHER

Commercial T4 phage cocktail

Treatment as recommended by the manufacturer (Microgen phages)

OTHER

standard oral rehydration solution (ORS)

Standard hospital treatment with ORS

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Shafiqul A Sarker, MD, PhD · Clinical Sciences Division, ICDDR,B, Mohakhali, Dhaka 1212, Bangladesh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
24 Months
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00937274 on ClinicalTrials.gov